Skip to main content
SpringerLink
Log in

Future Directions in the Management of Non-melanoma Skin Cancer

  • Chapter
Non-melanoma Skin Cancer of the Head and Neck

Part of the book series: Head and Neck Cancer Clinics ((HNCC))

  • 791 Accesses

Abstract

The current and future management of non-melanoma skin cancer (NMSC)—predominantly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—represents a significant public health problem worldwide. Australia has one of the highest rates of skin cancer in the world, with data showing that NMSC is five times more common than all other cancers combined [1]. The sun-exposed head and neck (HN) is the most common location, with incidence rates continuing to rise 3–10 % per year. Although BCC is more common, the vast majority of NMSCs are localized and easily treated with simple excision. However, 5 % are considered high-risk (nearly always SCC) and metastasize to regional lymph nodes with the potential for distant spread [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Staples MP, Elwood E, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.

    PubMed  Google Scholar 

  2. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med. 2001;344:975–83.

    Article  CAS  PubMed  Google Scholar 

  3. Schollkopf C, Rosendahl D, Rostgaard K, et al. Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer. 2007;121:151–6.

    Article  CAS  PubMed  Google Scholar 

  4. Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS. 1999;10:795–802.

    Article  CAS  PubMed  Google Scholar 

  5. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177–86.

    Article  CAS  PubMed  Google Scholar 

  6. Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64:1421–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Australian Institute of Health and Welfare (AIHW). Health system expenditures on cancer and other neoplasms in Australia 2000–2001. AIHW cat. no. HWE 29. Health and Welfare Expenditure Series No. 22. Canberra: Australian Institute of Health and Welfare; 2005.

    Google Scholar 

  8. Oddone N, Gary J, Morgan GJ, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck. The Immunosuppression, Treatment, Extranodal Spread, and Margin Status (ITEM) Prognostic Score to Predict Outcome and the Need to Improve Survival. Cancer. 2009;115:1883–91.

    Article  PubMed  Google Scholar 

  9. Veness MJ, Porceddu S, Palme CE, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31.

    Article  PubMed  Google Scholar 

  10. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.

    Article  PubMed  Google Scholar 

  11. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.

    Article  CAS  PubMed  Google Scholar 

  12. Denic S. Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol. 1999;22:32–4.

    Article  CAS  PubMed  Google Scholar 

  13. Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil and bleomycin. Cancer. 1990;66:1692–6.

    Article  CAS  PubMed  Google Scholar 

  14. Porceddu SV, Campbell B, Rischin D, et al. Postoperative chemo-radiotherapy for high-risk head and neck squamous cell carcinoma (HNSCC). Int J Radiat Oncol Biol Phys. 2004;60:365–73.

    Article  PubMed  Google Scholar 

  15. O’Hara J, Ferlito A, Takes RP, Rinaldo A, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland – a review of current recommendations. Head Neck. 2011;33:1789–95.

    Article  PubMed  Google Scholar 

  16. Kirke DN, Porceddu S, Wallwork BD, et al. Pathologic occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid. Otolaryngol Head Neck Surg. 2011;144:549–51.

    Article  PubMed  Google Scholar 

  17. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26:727–32.

    Article  PubMed  Google Scholar 

  18. Dona E, Veness MJ, Cakir B, et al. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg. 2003;73:692–6.

    Article  PubMed  Google Scholar 

  19. Ying YM, Johnson JT, Myers EN. Squamous cell carcinoma of the parotid gland. Head Neck. 2006;28:626–32.

    Article  PubMed  Google Scholar 

  20. O’Brien CJ, McNeil EB, McMahon JD, et al. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23:744–8.

    Article  PubMed  Google Scholar 

  21. Machtay M, Moughan M, Trotti T, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.

    Article  CAS  PubMed  Google Scholar 

  22. Donatelli-Lassig AA, Duffy SA, Fowler KE, et al. The effect of neck dissection on quality of life after chemoradiation. Otolaryngol Head Neck Surg. 2008;139:511–8.

    Article  PubMed  Google Scholar 

  23. Panizza B, Solares CA, Redmond M, et al. Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2012;34:1622–7.

    Article  PubMed  Google Scholar 

  24. Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perinerual spread of malignancy: comparing ‘targeted MRI’ with the historic findings following surgery. Head Neck. 2011;33:469–75.

    Article  CAS  PubMed  Google Scholar 

  25. Barnett CM, Foote MC, Panizza B. Cutaneous head and neck malignancies with perineural spread to contralateral cranial nerves: an argument for extending postoperative radiotherapy volume. J Clin Oncol. 2013;31:2291–3.

    Article  Google Scholar 

  26. Bischoff EPE. Microscopic analysis of the anastamosis between the cranial nerves. Hanover: University Press of New England; 1997. p. 1–138.

    Google Scholar 

  27. Myckatyn TM, Mackinnon SE. A review of facial nerve anatomy. Semin Plast Surg. 2004;18:5–12.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Ballantyne AJ, McCarten AB, Ibanez ML. The extension of cancer of the head and neck through peripheral nerves. Am J Surg. 1963;106:651–7.

    Article  CAS  PubMed  Google Scholar 

  29. Grégoire V, Levendag P. CT-based delineation of lymph node levels in the N0 neck: DAHANCA, EORTC, GORTEC, RTOG consensus guidelines. http://www.rtog.org/LinkClick.aspx?fileticket=TjrmNiHXly8%3d&tabid=229. Accessed 16 June 2013.

  30. Scott AM, Gunawardana DH, Bartholomeusz D, et al. PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study. J Nucl Med. 2008;49:1593–600.

    Article  PubMed  Google Scholar 

  31. Wagner JD, Schauwecker DS, Davidson D, et al. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol. 2001;77:237–42.

    Article  CAS  PubMed  Google Scholar 

  32. Boswell JS, Flam MS, Tashjian DN, et al. Basal cell carcinoma metastatic to cervical lymph nodes and lungs. Dermatol Online J. 2006;12:9.

    PubMed  Google Scholar 

  33. Cho SB, Chung WG, Yun M, et al. Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients. Dermatol Surg. 2005;31:442–6.

    Article  CAS  PubMed  Google Scholar 

  34. Merkel PET Phase II ‘MP3’ Study (NCT01013779). http://www.trog.com.au/Portals/0/Open%20Trials/TROG%2009%2003_Amend%202%2010%20March%202011_Clean.pdf. Accessed 16 June 2013.

  35. Nottage M, Francesconi A, Houston K, et al. A prospective study investigating the impact of definitive chemoradiation in locoregionally advanced squamous cell carcinoma of the skin. J Clin Oncol. 2012;30(suppl; abstr 8538).

    Google Scholar 

  36. Maubec E, Petrow P, Duvillard P, et al. Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: final results of a phase II multicenter study. J Clin Oncol. 2010;28(suppl; abstr 8510).

    Google Scholar 

  37. Weber RS, Lustig RA, El-Naggar AK, et al. Gefitinib for advanced cutaneous squamous cell carcinoma of head and neck: phase II trial. J Clin Oncol. 2009;27(suppl; abstr 6054).

    Google Scholar 

  38. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal cell carcinoma. N Engl J Med. 2009;361:1164–72.

    Article  Google Scholar 

  39. Cirrone F, Harris CS. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Clin Ther. 2012;34:2039–50.

    Article  CAS  PubMed  Google Scholar 

  40. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with the basal cell nevus syndrome. N Engl J Med. 2012;366:2180–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Atwood SX, Mischa L, Lee A, et al. GLI activation by atypical protein kinase Cι/λ regulates the growth of basal cell carcinomas. Nature. 2013;494:484–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Oncology, Oceania Oncology Bundaberg, Bundaberg, QLD, Australia

    Gerard Adams BSc, MB ChB, MRCP, FRCR, FRANZCR

  2. School of Medicine, University of Queensland, St Lucia, QLD, Australia

    Gerard Adams BSc, MB ChB, MRCP, FRCR, FRANZCR

  3. Radiation Oncology, University of Queensland, St Lucia, QLD, Australia

    Sandro V. Porceddu

  4. Princess Alexandra Hospital, Brisbane, QLD, Australia

    Sandro V. Porceddu

Authors
  1. Gerard Adams BSc, MB ChB, MRCP, FRCR, FRANZCR
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandro V. Porceddu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerard Adams BSc, MB ChB, MRCP, FRCR, FRANZCR .

Editor information

Editors and Affiliations

  1. University of Sydney, Westmead Hospital, Sydney, Australia

    Faruque Riffat

  2. Westmead Hospital, University of Sydney, Sydney, Australia

    Carsten E. Palme

  3. Westmead Hospital, University of Sydney, Sydney, Australia

    Michael Veness

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi

About this chapter

Cite this chapter

Adams, G., Porceddu, S.V. (2015). Future Directions in the Management of Non-melanoma Skin Cancer. In: Riffat, F., Palme, C., Veness, M. (eds) Non-melanoma Skin Cancer of the Head and Neck. Head and Neck Cancer Clinics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2497-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-2497-6_13

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-2496-9

  • Online ISBN: 978-81-322-2497-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation